Meyers Michael L. (CIK 0001664204)

Latest company ownership

SNDX - Syndax Pharmaceuticals Inc

Role: SVP, Chief Medical Officer

Shares held

17,350

Last filed at

Feb 3, 2022

Confidence Score

50.0

2025Q4

Confidence Score History

2018Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jan 31, 2022	Feb 3, 2022	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	86.3	+1,714	7.95%	✗	$21.2K
Apr 26, 2021	Apr 28, 2021	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	82.5	+500	3.30%	✗	$7.7K
Jul 31, 2020	Feb 5, 2021	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	91.3	+4,436	41.34%	✗	$42.5K
Mar 21, 2019	Mar 25, 2019	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	55.0	+8	0.11%	✗	$39
Mar 21, 2019	Mar 22, 2019	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	90.0	+1,104	18.05%	✗	$5.4K
Jan 31, 2019	Feb 8, 2019	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	91.3	+3,720	155.13%	✗	$17.7K
Oct 30, 2018	Nov 7, 2018	Syndax Pharmaceuticals Inc	SVP, Chief Medical Officer	Buy	85.0	+200	9.10%	✗	$958